IUMPA: The presentation of the aim of using the intrauterine drug delivery system for the hormone preoperative treatment of endometrial cancer and the hormone treatment of abnormal uterine bleeding

Andrzej J. Kowalski; Andrzej Zdziennicki; Jakub Welfel; Grzegorz Surkont; Jacek Suzin

eISSN: 2299-0038
ISSN: 1643-8876

Menopause Review/Przegląd Menopauzalny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

1/2007
vol. 6

Send email

Copy url:

abstract:

IUMPA: The presentation of the aim of using the intrauterine drug delivery system for the hormone preoperative treatment of endometrial cancer and the hormone treatment of abnormal uterine bleeding

Andrzej J. Kowalski

,

Andrzej Zdziennicki

,

Jakub Welfel

,

Grzegorz Surkont

,

Jacek Suzin

Przegląd Menopauzalny 2007; 1: 16–18

Online publish date: 2007/03/02

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Kowalski A, Zdziennicki A, Welfel J, Surkont G, Suzin J. IUMPA: The presentation of the aim of using the intrauterine drug delivery system for the hormone preoperative treatment of endometrial cancer and the hormone treatment of abnormal uterine bleeding. Menopause Review/Przegląd Menopauzalny. 2007;6(1):16-18.

APA

Kowalski, A., Zdziennicki, A., Welfel, J., Surkont, G.,  & Suzin, J. (2007). IUMPA: The presentation of the aim of using the intrauterine drug delivery system for the hormone preoperative treatment of endometrial cancer and the hormone treatment of abnormal uterine bleeding. Menopause Review/Przegląd Menopauzalny, 6(1), 16-18.

Chicago

Kowalski, Andrzej J., Andrzej Zdziennicki, Jakub Welfel, Grzegorz Surkont,  and Jacek Suzin. 2007. "IUMPA: The presentation of the aim of using the intrauterine drug delivery system for the hormone preoperative treatment of endometrial cancer and the hormone treatment of abnormal uterine bleeding". Menopause Review/Przegląd Menopauzalny 6 (1): 16-18.

Harvard

Kowalski, A., Zdziennicki, A., Welfel, J., Surkont, G.,  and Suzin, J. (2007). IUMPA: The presentation of the aim of using the intrauterine drug delivery system for the hormone preoperative treatment of endometrial cancer and the hormone treatment of abnormal uterine bleeding. Menopause Review/Przegląd Menopauzalny, 6(1), pp.16-18.

MLA

Kowalski, Andrzej J. et al. "IUMPA: The presentation of the aim of using the intrauterine drug delivery system for the hormone preoperative treatment of endometrial cancer and the hormone treatment of abnormal uterine bleeding." Menopause Review/Przegląd Menopauzalny, vol. 6, no. 1, 2007, pp. 16-18.

Vancouver

Kowalski A, Zdziennicki A, Welfel J, Surkont G, Suzin J. IUMPA: The presentation of the aim of using the intrauterine drug delivery system for the hormone preoperative treatment of endometrial cancer and the hormone treatment of abnormal uterine bleeding. Menopause Review/Przegląd Menopauzalny. 2007;6(1):16-18.

Introduction: In the review the intrauterine drug delivery system releasing medroxyprogesterone acetate is shown. This system has been used for preoperative treatment of endometrial cancer and hormone treatment of abnormal uterine bleeding. The system is named IUMPA (IntraUterine MedroxiProgesterone Acetate).
Aim: IUMPA-1 has been prepared for preoperative treatment of endometrial cancer, IUMPA-2 for cases of abnormal bleeding from the uterine cavity.
Methods: Medroxyprogesterone acetate was used in both systems.
Materials: IUMPA-1 – patients with endometrial cancer, IUMPA-2 – patients with abnormal bleeding.
Conclusions: IUMPA-1 was found to be an effective system for preoperative treatment of endometrial cancer. IUMPA-2 only in cases with relative hyperoestrogenism, in which increased administration of progestogen was needed, was successful. In other cases success was not noted.
Recapitulation: The Drug Delivery System IUMPA can be used as an alternative or supplementary instrument in selected gynaecological cases.

keywords:

IUMPA: The presentation of the aim of using the intrauterine drug delivery system for the hormone preoperative treatment of endometrial cancer and the hormone treatment of abnormal uterine bleeding

Andrzej J. Kowalski , Andrzej Zdziennicki , Jakub Welfel , Grzegorz Surkont , Jacek Suzin

endometrial hyperplasia, endometrial cancer, hormone therapy, IUMPA

Andrzej J. Kowalski

,

Andrzej Zdziennicki

,

Jakub Welfel

,

Grzegorz Surkont

,

Jacek Suzin